首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING POLYCYSTIC OVARY SYNDROME

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING POLYCYSTIC OVARY SYNDROME

机译:用于预防和治疗多囊卵巢综合征的药物组合物

摘要

FIELD: pharmaceuticals.;SUBSTANCE: invention relates to the field of pharmacology, in particular, to pharmaceutical compositions for preventing and treating polycystic ovary syndrome (PCOS), containing the following components, % wt.: vitamin D3 - from 0.0006 to 0.001; vitamin B9 (folic acid) - from 0.004 to 0.006; alpha lipoic acid - from 5.3 to 7.1; myo inositol - from 89.9 to 92.5; D-chiro-inositol - from 2.0 to 2.6; manganese gluconate - from 0.35 to 0.47.;EFFECT: production of pharmaceutical compositions for preventing and treating polycystic ovary syndrome (PCOS) with increased efficiency of use and with an increased duration of effect (bodily system normalisation period).;1 cl, 6 tbl
机译:领域:药品。物质:发明领域尤其涉及用于预防和处理多囊卵巢综合征(PCOS)的药理学组合物,含有以下组分,%wt .:维生素D3- 0.0006至0.001; 维生素B9(叶酸) - 0.004至0.006; α硫辛酸 - 从5.3到7.1; Myo肌醇 - 从89.9到92.5; D-Chiro-intositol - 从2.0到2.6; 锰葡萄糖酸盐 - 从0.35到0.47。;效果:制备药物组合物,用于预防和治疗多囊卵巢综合征(PCOS)的使用效率提高,效果持续时间(体系归一化期间)。1 Cl,6 Tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号